TB-09

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTB-09

Drug Alias Nametrispecific antibody based therapeutic (Biotecnol)TB-09

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibodyBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryPortugal

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBiotecnol Sa

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBiotecnol Sa

Active IndicationsN/A

Inactive IndicationsHematologic Neoplasms

Other Information

ATC CodeN/A